1 / 2
Custom Tirzepatide CAS 2023788-19-2: China Suppliers & Factory for Effective Weight Management Solution Manufacturer, Pricelist
Product Description
Tirzepatide is specially designed to target two key receptors in the body: glucose-dependent insulin secretagogue polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism of action enables Tirzepatide to simultaneously address multiple aspects of metabolic health, providing a comprehensive solution for people who have difficulty managing their weight.
Mechanism & Efficacy
Tirzepatide is a dual GLP-1/GIP receptor agonist designed to improve glycemic control, reduce body weight, and support overall metabolic health. It has been studied extensively in clinical trials for type 2 diabetes and obesity management.
Dosage & Clinical Use
Tirzepatide (brand names include Mounjaro®/Zepbound®) is used for glycemic control and weight management, administered as a once‑weekly subcutaneous injection. Available strengths typically include: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per dose, adjusted based on clinical response and tolerability.
Frequently Asked Questions
What is the main purpose of Tirzepatide?
Tirzepatide is primarily used for improving glycemic control in adults with type 2 diabetes and for chronic weight management in adults with obesity or overweight conditions who have weight-related comorbidities.
How does the dual mechanism of Tirzepatide work?
It acts as an agonist for both GIP and GLP-1 receptors. This unique dual action enhances insulin secretion, suppresses excessive glucagon, slows gastric emptying, and significantly reduces appetite, providing a comprehensive metabolic benefit.
How often is Tirzepatide administered?
Tirzepatide is administered as a once-weekly subcutaneous injection. It is typically injected under the skin of the abdomen, thigh, or upper arm.
What are the available dosage strengths?
The medication is available in pre-filled pens with strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Treatment usually starts at a lower dose and is escalated gradually to minimize side effects.
What are the most common side effects?
The most frequently reported side effects are gastrointestinal in nature. These include nausea, diarrhea, decreased appetite, vomiting, and constipation. They are typically mild to moderate and often subside over time.
Can Tirzepatide be used with other medications?
Yes, it can be prescribed alongside other diabetes medications like metformin. However, combining it with insulin or sulfonylureas may require careful dosage adjustments by a healthcare provider to reduce the risk of hypoglycemia.
